Delila Gasi Tandefelt
Delila Gasi Tandefelt
PhD
Verified email at gu.se - Homepage
Title
Cited by
Cited by
Year
Plasma AR and abiraterone-resistant prostate cancer
A Romanel, DG Tandefelt, V Conteduca, A Jayaram, N Casiraghi, ...
Science translational medicine 7 (312), 312re10-312re10, 2015
3432015
Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution …
V Conteduca, D Wetterskog, MTA Sharabiani, E Grande, ...
Annals of Oncology 28 (7), 1508-1516, 2017
1902017
Serial next-generation sequencing of circulating cell-free DNA evaluating tumor clone response to molecularly targeted drug administration
JS Frenel, S Carreira, J Goodall, D Roda, R Perez-Lopez, N Tunariu, ...
Clinical Cancer Research 21 (20), 4586-4596, 2015
1732015
Overexpression of prostate-specific TMPRSS2 (exon 0)-ERG fusion transcripts corresponds with favorable prognosis of prostate cancer
KG Hermans, JL Boormans, D Gasi, GJHL van Leenders, G Jenster, ...
Clinical Cancer Research 15 (20), 6398-6403, 2009
1002009
ETS fusion genes in prostate cancer
DG Tandefelt, J Boormans, K Hermans, J Trapman
Endocrine-related cancer 21 (3), R143-R152, 2014
692014
A 36-gene signature predicts clinical progression in a subgroup of ERG-positive prostate cancers
DG Tandefelt, JL Boormans, HA van der Korput, GW Jenster, J Trapman
European urology 64 (6), 941-950, 2013
372013
Overexpression of full-length ETV1 transcripts in clinical prostate cancer due to gene translocation
D Gasi, HA Van Der Korput, HC Douben, A De Klein, CM De Ridder, ...
PloS one 6 (1), e16332, 2011
242011
Plasma tumour DNA as an early indicator of treatment response in metastatic castration-resistant prostate cancer
V Conteduca, D Wetterskog, E Scarpi, A Romanel, G Gurioli, A Jayaram, ...
British journal of cancer 123 (6), 982-987, 2020
82020
Androgen regulation of ETS gene fusion transcripts in prostate cancer
D Gasi, J Trapman
Androgen Action, 335-348, 2011
82011
Identification of single nucleotide variants using position-specific error estimation in deep sequencing data
D Kleftogiannis, M Punta, A Jayaram, S Sandhu, SQ Wong, DG Tandefelt, ...
BMC medical genomics 12 (1), 1-12, 2019
52019
Spanish Oncology Genitourinary Group, Demichelis F, De Giorgi U, Gonzalez-Billalabeitia E, Attard G. Androgen receptor gene status in plasma DNA associates with worse outcome …
V Conteduca, D Wetterskog, MTA Sharabiani, E Grande, ...
Ann Oncol 28, 1508-1516, 2017
52017
Circulating cell-free DNA: Translating prostate cancer genomics into clinical care
DG Tandefelt, J de Bono
Molecular aspects of medicine 72, 100837, 2020
32020
Plasma AR and abiraterone-resistant prostate cancer. Sci Transl Med. 2015; 7: 312re10
A Romanel, D Gasi Tandefelt, V Conteduca, A Jayaram, N Casiraghi, ...
3
Re: Delila Gasi Tandefelt, Joost L. Boormans, Hetty A. Van Der Korput, Guido W. Jenster, Jan Trapman. A 36-gene Signature Predicts Clinical Progression in a Subgroup of ERG …
N Sampson, P Berger, H Klocker
European urology 65 (6), e102-e103, 2014
12014
Association of androgen receptor (AR) status in plasma DNA with outcome on enzalutamide (enza) or abiraterone (abi) for castration resistant prostate cancer (CRPC).
V Conteduca, D Wetterskog, MTA Sharabiani, A Jayaram, S Salvi, ...
Journal of Clinical Oncology 35 (15_suppl), 5060-5060, 2017
2017
Serial Next Generation Sequencing of Cfdna to Monitor Phase I Targeted Drug Administration
J Frenel, S Carreira, J Goodall, D Roda-Perez, A Smith, J Mateo, M Ong, ...
Annals of Oncology 25, v1, 2014
2014
Targeted deep sequencing from circulating plasma DNA as a multipurpose biomarker in pts (pts) referred for phase I trials.
JS Frenel, S Carreira, J Goodall, D Roda, AD Smith, J Mateo, M Ong, ...
Journal of Clinical Oncology 32 (15_suppl), 11051-11051, 2014
2014
Expression and Function of ETS Genes in Prostate Cancer
D Gasi
2013
A 36 gene-signature of primary prostate tumor samples with ERG overexpression selects for subgroups with poor clinical progression
DG Tandefelt, JL Boormans, HA van der Korput, GW Jenster, J Trapman
Expression and Function of ETS Genes in Prostate Cancer, 131, 2013
2013
TMPRSS2-ERG and other ETS gene fusions in prostate cancer
DG Tandefelt, J Boormans, K Hermans, J Trapman
Expression and Function of ETS Genes in Prostate Cancer, 11, 2013
2013
The system can't perform the operation now. Try again later.
Articles 1–20